Atlas Pharmaceuticals

Atlas Pharmaceuticals Overview

  • Founded
  • 2017
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 9
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Atlas Pharmaceuticals General Information

Description

Developer of sterile, non-sterile, controlled, and non-controlled medications for humans and animals. The company's medications include lidocaine, sodium chloride, atropine, acetylcysteine, buprenorphine, doxycycline, and other related products, which are crafted using bioburden, sterility, endotoxin, potency, preservative effectiveness, and particulate monitoring processes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 711 East Carefree Highway
  • Suite 207
  • Phoenix, AZ 85085
  • United States
+1 (623) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atlas Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atlas Pharmaceuticals‘s full profile, request access.

Request a free trial

Atlas Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Robert Eaton President & Chief Executive Officer
Nancy Costlow Director